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Abstract: Blood oxygenation level-dependent (BOLD) contrast functional magnetic resonance imaging
(fMRI) is a widely used technique to map brain function, and to monitor its recovery after stroke. Since
stroke has a vascular etiology, the neurovascular coupling between cerebral blood flow and neural
activity may be altered, resulting in uncertainties when interpreting longitudinal BOLD signal changes.
The purpose of this study was to demonstrate the feasibility of using a recently validated breath-hold
task in patients with stroke, both to assess group level changes in cerebrovascular reactivity (CVR) and
to determine if alterations in regional CVR over time will adversely affect interpretation of task-related
BOLD signal changes. Three methods of analyzing the breath-hold data were evaluated. The CVR
measures were compared over healthy tissue, infarcted tissue and the peri-infarct tissue, both sub-
acutely (2 weeks) and chronically (4 months). In this cohort, a lack of CVR differences in healthy
tissue between the patients and controls indicates that any group level BOLD signal change observed
in these regions over time is unlikely to be related to vascular alterations. CVR was reduced in the
peri-infarct tissue but remained unchanged over time. Therefore, although a lack of activation in this
region compared with the controls may be confounded by a reduced CVR, longitudinal group-level
BOLD changes may be more confidently attributed to neural activity changes in this cohort. By includ-
ing this breath-hold-based CVR assessment protocol in future studies of stroke recovery, researchers
can be more assured that longitudinal changes in BOLD signal reflect true alterations in neural activity.
Hum Brain Mapp 36:1755–1771, 2015. VC 2015 TheAuthors Human Brain Mapping Published by Wiley Periodicals, Inc.
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INTRODUCTION
Over recent decades, functional magnetic resonance
imaging (fMRI) has become a useful tool when studying
the recovery of brain function following a stroke or other
focal brain injury. Interpretations of fMRI findings should
take into account the limitations of this technique, and fac-
tors that influence the fMRI-derived blood oxygenation
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action level-dependent (BOLD) signal [Logothetis, 2008].
BOLD contrast fMRI is not only dependent on increased
oxygen metabolism due to increased neural activity since
activation-related differences also depend on changes in
cerebral blood flow (CBF) and cerebral blood volume
[Buxton, 2012; Davis et al., 1998; Hoge et al., 1999]. Since
stroke has a vascular etiology, this may alter the normal
neurovascular coupling between CBF and oxygen con-
sumption (taken as representative of neural activity), with
resulting uncertainty when interpreting BOLD signal
changes.
Reductions in cerebrovascular reactivity (CVR), the
response of cerebral blood vessels to a vasodilatory stimu-
lus, are associated with factors that predispose to stroke
[Gupta et al., 2012; Markus, 2001]. Acute vascular changes
as a result of stroke may further reduce CVR. Reductions
in CVR will lead to alterations in neurovascular coupling;
that is, a given change in neural activity will no longer be
represented by the same BOLD signal change. Regional
changes in CVR and BOLD signal have been observed in
adults after stroke [Krainik et al., 2005]. Combining BOLD
fMRI with a vasoactive stimulus such as CO2 provides a
robust means of characterizing CVR [Shiino et al., 2003].
In many studies of clinical populations, an increase in arte-
rial CO2 levels is achieved using administration of a vaso-
dilatory gas through a face mask during scanning [Heyn
et al., 2010]. In patients with stroke, this may not always
be desirable or feasible due to the discomfort of the experi-
mental setup.
A simple method to measure BOLD CVR in patient
groups using a breath-hold task has been developed
[Bright and Murphy, 2013; Murphy et al., 2011]. Breath-
holding offers an alternative to gas administration, and
provides a similar BOLD CVR measure [Kastrup et al.,
2001]. Until recently, it had been assumed that the degree
of cooperation to perform a breath-holding task would
vary too greatly across a patient population to provide a
reliable measure of CVR [Spano et al., 2013]. However,
Bright and Murphy [2013] have shown that by monitoring
end-tidal CO2 levels during a breath-hold task, robust and
repeatable measures of CVR can be obtained, even if the
breath-hold task is poorly performed. This opens the way
to using such a task in a stroke population to account for
CVR differences. These measures can, in turn, be used to
adjust the BOLD signal to more accurately reflect the neu-
ral responses to stimuli in a task-related fMRI study [Mur-
phy et al., 2011].
Changes in CVR over time may potentially be problem-
atic, particularly in longitudinal fMRI studies investigating
recovery after the onset of stroke [Saur, 2006; Ward et al.,
2003]. In the longitudinal study by Saur et al.[2006], inves-
tigating language recovery following a left hemisphere
stroke, there was no activity in the left hemisphere lan-
guage areas, within the same vascular territory as the
infarct, during the first few days after the stroke. Although
this was interpreted as a lack of language-related neural
activity caused by the stroke, an alternative explanation is
that the absence of BOLD signal was the result of altered
cerebral haemodynamics rather than a decline in neural
activity per se. For example, it has been shown that the
morphology of the haemodynamic response function
(HRF) in the left perisylvian area is altered in some apha-
sic patients following a stroke [Bonakdarpour et al., 2007].
In another study, the characteristics of the HRF response
to an auditory comprehension task changed as patients
progressed from the acute to the sub-acute phase of stroke
[Altamura et al., 2009]. In addition, major arterial stenoses
result in a compensatory reduction in distal cerebrovascu-
lar resistance, which in turn will alter CVR. Thus, it has
been demonstrated that the HRF ipsilateral to an internal
carotid artery stenosis has different temporal characteris-
tics to that in the contralateral hemisphere [Carusone and
Srinivasan, 2002]. Furthermore, large vessel cervical or cer-
ebral artery steno-occlusive disease can induce competitive
intra-cerebral redistribution of flow from territories with
low vasodilatory reserve to those with high reserve [Sobc-
zyk et al., 2014]. Thus without taking into account acute
and chronic changes in normal CVR, task-related BOLD
signal changes over time, particularly in longitudinal stud-
ies of stroke, are prone to misinterpretation.
One fMRI study investigating aphasic stroke recovery
has used a simple breath-hold task to account for differen-
ces in haemodynamic responsiveness in stroke patients
[van Oers et al., 2010]. One advantage of using the Bright
and Murphy [2013] approach, compared with the method
used in that study, is that it quantifies the end-tidal CO2
changes to the breath-holds. This compensates for variabil-
ity in task performance across the patients, providing
more reliable quantification of the CVR. The end-tidal CO2
measure provides an accurate model of the expected
BOLD response for an individual patient, allowing for the
different delays in the breath-hold response across varying
brain regions. In addition, the use of paced breathing
between breath-hold challenges in the Bright and Murphy
[2013] method leads to a more consistent baseline condi-
tion, and thus a less variable measure [Scouten and
Schwarzbauer, 2008]. Finally, the Bright and Murphy
[2013] approach uses end-expiration measures, avoiding
the biphasic BOLD response that is observed in end-
inspiration challenges [Thomason and Glover, 2008]. This
leads to a more repeatable starting point for the breath-
hold challenge, resulting in improved reproducibility
[Scouten and Schwarzbauer, 2008].
The purpose of this study is to demonstrate the feasibil-
ity of this breath-hold technique in patients with stroke,
and to determine whether, in this cohort, alterations in
CVR in the peri-infarct tissue over time might result in misin-
terpretation of group-level task-related BOLD signal changes.
Three methods of analyzing the data were investigated:
GlobOpt, in which a single model of the BOLD response was
derived from the end-tidal CO2 trace;VoxOpt, when the delay
between the end-tidal CO2 and fMRI time series was allowed
to vary on a voxel-wise basis to account for slower regional
haemodynamic responses; and RHsig, a method by which a
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BOLDmodel was derived from the contralesional right hemi-
sphere and does not require measurement of the end-tidal
CO2. The CVR measures were compared in healthy, peri-
infarct tissue and infarcted tissue at two time points after the
ictus, in the sub-acute and chronic phase. The peri-infarct tis-
sue was specifically included in the analysis as some studies
have attributed the level of BOLD signal change in this region
to stroke recovery [Heiss et al., 1999, 2006; Rosen et al., 2000;
Saur et al., 2006]. The results demonstrate the use of this
method to assess CVR in a cohort of patients with stroke, and
suggest that inclusion of this protocol in longitudinal BOLD
studies of stroke recovery will allow more confident interpre-
tation of group results.
METHODS
Participants
Forty-six stroke patients (referred to as the PT group) with
left lateralized cerebral infarction were scanned (30 male, aver-
age age 61.2 years, range 26–79 years). Table I shows their
demographic data, including cerebrovascular risk factors,
details of the size and site of the stroke lesion, the mode and
outcome of vascular imaging and the timing of the fMRI scans.
The majority of patients had embolic stroke that was either
from a cardio-embolic source (e.g. atrial fibrillation, or patent
foramen ovale), or artery-to-artery embolism (e.g. from the
carotid tree). There were 18 patients with occlusive arterial dis-
ease either in the intracranial vessels (e.g. due to stenosis or
fresh thrombus) or dissection in the carotid tree.
Twenty-four patients were scanned in the sub-acute
phase post-stroke (SPPS, also referred to as Sess1) and 42
in the chronic phase post-stroke (CPPS, also referred to as
Sess2) (Fig. 1a). Mean time after stroke for SPPS was 14
days (range 5–28 days) and for CPPS was 114 days (range
84–200 days). Additionally, 26 healthy volunteers (referred
to as the HV group) were scanned (9 male, average age
56.5 years, range 37–78 years), 17 of whom were scanned
again after approximately 100 days. There was no
between-group differences in age (t-test P5 0.15) or sex
(Fisher’s exact test P5 0.5). The National Research Ethics
Service Committee (West London) approved the study.
Scanning Parameters
MRI data were obtained on a Siemens Magnetom Trio 3
Tesla scanner. Whole brain, dual-echo, BOLD GE-
echoplanar imaging (EPI) images (repetition time
(TR)5 2 s, echo time (TE1)5 13 ms, TE25 31 ms, voxel-
size 3.5 3 3.5 3 3 mm3, 36 slices) were collected during a
breath-hold task (see below). Only the second echo was
analysed in this study. Quadratic shim gradients were
used to correct for magnetic field inhomogeneities within
the brain, and residual field artefacts were compensated
after acquiring fieldmap images. A high-resolution 1 mm3
isotropic T1-weighted whole-brain structural image was
obtained.
In addition, diagnostic diffusion-weighted MRI (DWI)
and apparent diffusion co-efficient (ADC) imaging
obtained by the clinical stroke services at the time of each
patient’s admission to hospital was available to assist with
determination of the boundary of regional infarction (see
below). DWI and ADC images were performed in a Sie-
mens Verio 3T scanner via diffusion-weighted EPI sequen-
ces. Nineteen DWI axial slices were acquired at b5 0, 500
and 1,000 s/mm2 covering the entire brain. Other imaging
parameters were: TR/TE 4,600/90 ms, field of view 267 3
267, matrix 192 3 192, slice thickness 5 mm, with 6.5 mm
spacing. The ADC maps were acquired with identical
parameters with b5 1,000 s/mm2 .
Breath-Hold Paradigm and End-Tidal
CO2 Pre-Processing
Each participant performed a breath-hold task during the
BOLD imaging to measure vascular reactivity [Bright and
Murphy, 2013; Murphy et al., 2011]. The task consisted of
14 s of natural breathing, followed by 16 s paced breathing,
then a 15 s end-expiration breath-hold down to an unforced
depth. After the breath-hold, a quick exhalation of residual
air was performed prior to a return to natural breathing,
which allowed the measurement of end-tidal CO2 increases
as a result of the breath-hold. This cycle was repeated six
times over the course of the scan. The participants were
trained outside the scanner and instructed to proceed to
each stage by a series of visual pictorial and written cues
presented at the centre of a screen.
End-tidal CO2 traces were recorded throughout the
experiment at a sampling frequency of 200 Hz, via a nasal
cannula attached to a Medrad Veris capnograph. The
recorded end-tidal CO2 was converted to units of mmHg.
A home-grown peak-detection algorithm was used to
determine end-tidal CO2 values by determining the partial
pressure of CO2 at the end of each breath. A linear inter-
polation was made between the end-tidal CO2 measure of
the final breath before the breath-hold and the quick exha-
lation CO2 measure after the breath-hold. After this inter-
polation, a scale invariant convolution with a HRF was
performed so that the scaling of the end-tidal CO2 regres-
sors remains the same. Convolution with a standard dou-
ble gamma variate HRF [Friston et al., 1998] was
performed because it has been demonstrated that more
variance can be explained in the BOLD breath-hold data
[Murphy et al., 2011]. In this way, the amplitude of the
regressors reflects the true increase in end-tidal CO2 so
that a quantitative measure of CVR could be made.
fMRI Pre-Processing
The BOLD breath-hold data were corrected for motion
using AFNI’s 3dvolreg program by performing a rigid
body alignment of each volume to the middle volume
(http://afni.nimh.nih.gov/afni). Each voxel’s time series
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was converted to a %BOLD signal time series by dividing
by the mean across time points. A global %BOLD time
series was calculated for each participant by averaging
over all voxels in the brain. Linear drifts were removed
from the data. No smoothing was performed to avoid con-
tamination of CVR values between different regions.
Analyses of Breath-Hold Data—GlobOpt,
VoxOpt and RHsig
With the aim of determining the best way to analyse the
breath-hold data, three analyses were performed: Global
Optimization (GlobOpt), Voxel-wise Optimization (VoxOpt)
and Right Hemisphere Signal (RHsig; Fig. 1c). First, to
remove delays between the BOLD data and the end-tidal
CO2 trace that are caused both by physiological processes
(such as the time for alveolar diffusion of CO2 in the lung,
and the time for blood to travel between the lungs and
brain) and by the experimental apparatus (delays along
the long sampling line between the participant in the MR
scanner and the capnograph), the delay was optimized to
the corresponding global BOLD signal (see top panel in
Fig. 1c). In practice, this was performed by temporally
shifting the end-tidal CO2 trace between 215 s and 115 s
in 0.1 s steps, to find the delay that explained the most
Figure 1.
(a) Lesion Distributions. The spatial distribution of the patient’s
acute infarct lesions is shown for both the Sub-acute Phase Post-
Stroke (SPPS also referred to as Sess1) and Chronic Phase Post-
Stroke (CPPS also referred to as Sess2) time points. The colour-
code of each voxel indicates how many patients had a lesion that
included that voxel. The Venn diagram shows how many patients
were scanned at each time point and the overlap between them.
(b) Masks. The schematic shows the masks used in the analysis.
(c) Analyses. The delay of each participant’s end-tidal CO2 trace
was initially optimised by aligning it to the corresponding global
BOLD signal time series. Three subsequent analyses types were
performed. GlobOpt: the optimised CO2 trace was fitted to each
voxel’s time series using a GLM. VoxOpt: the same CO2 trace was
fitted to the voxel’s time series but was allowed to vary tempo-
rally to optimise the fit. RHsig: the average BOLD time series sig-
nal from the right hemisphere was fitted to the time series of
every voxel in the brain. [Color figure can be viewed in the
online issue, which is available at wileyonlinelibrary.com.]
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variance in the global BOLD signal. This globally optimized
CO2 trace then formed the regressor for the GlobOpt analysis;
that is, it was fitted to each voxel’s time series with a general
linear model (GLM) using AFNI’s 3dDeconvolve function. The
beta weight from the regression for each voxel gives the
breath-hold response in that voxel in units of %BOLD signal
change permmHg change in end-tidal CO2.
The VoxOpt analysis differed from the GlobOpt analysis by
allowing the CO2 delay to be optimized on a voxel-wise
basis. In practice, a similar analysis was performed where
the CO2 trace was included as a regressor in a GLM. This
was repeated for each delay of the CO2 trace (215 s to 115 s
in 0.1 s steps from the globally optimized delay value). On a
voxel-wise basis, the delay at which the GLM explained the
most variance in that voxel was chosen as the optimal delay.
Again, the beta weight in that voxel for that delay gave the
breath-hold response in units of %BOLD signal change per
mmHg change in end-tidal CO2.
The final analysis, RHsig, provides a way of obtaining
breath-hold response maps if the CO2 trace is unavailable
or of too poor a quality to use. If an area of healthy tissue
can be defined, the average BOLD response across that
region provides a good model of the expected breath-hold
response that can be included as a regressor in a GLM. In
the RHsig analysis, it was assumed that the average
response over the entire right hemisphere is a good repre-
sentation of the BOLD signal response to the breath-hold
challenge. A similar approach was used by van Oers et al.
[2010]. This average was fitted to each voxel in a GLM, and
the derived beta weight for that voxel was the breath-hold
response in units of %BOLD (as a ratio of the %BOLD sig-
nal change of the RHsig, that is, 100% indicates a signal
with the same amplitude as the RHsig time series).
Lesion, Peri-infarct and Healthy Tissue Masks
Individual 3D lesion masks were manually delineated by
a neurologist (FG) and verified by a second neurologist
(RJSW). These were drawn one slice at a time, on T1-
weighted images using FSLView (http://www.fmrib.ox.ac.
uk/fsl/), with additional guidance from the diagnostic
acute post-stroke DWI and ADC sequences that were avail-
able in 41 subjects. DWI sequences reveal the early infarct
with high contrast, and were used to guide the boundaries
of the lesion on the high resolution T1-weighted structural
images [Saur et al., 2006; Mah et al., 2012]. Similar lesion
identification based on T1-weighted images is commonly
used in functional neuroimaging studies that investigate
recovery of cognitive functions after stroke, which can argu-
ably be confounded by changes in CVR [Bates et al., 2003;
Brownsett et al., 2014; Dronkers et al., 2004; Crinion et al.,
2006, Teki et al., 2013, Saur et al., 2006]. Identification of the
lesion manually, is considered gold standard when evaluat-
ing the efficacy of automated lesion segmentation algo-
rithms [Mah et al., 2014; Seghier et al., 2008]. Session
specific lesion masks were defined independently for each
of the SPPS and CPPS scans.
Two patients had acute infarcts that included lesions
(maximum volume 1.4 cm3) in the right hemisphere in
addition to the acute infarct in the left hemisphere (Fig.
1a). These were included in the acute lesion mask. Five
patients had an additional remote and small chronic lesion
(range of lesion volume: 0.09–30.6 cm3) that was excluded
from the acute lesion mask.
A schematic of the masks used in this study is shown in
Figure 1b. The acute lesion mask was denoted L-Lesion since
the acute stroke lesions were confined to the left hemisphere
in the majority of cases, and predominantly left-lateralized in
the few patients with bilateral acute strokes. A peri-infarct
tissue mask, L-PeriInfarct, was defined for each patient by
dilating the individual’s L-Lesion by 10 mm and then remov-
ing voxels that were in L-Lesion. The remaining left hemi-
sphere voxels outside L-Lesion and L-PeriInfarct constituted
the L-Healthy mask. Homologous masks were defined in the
right hemisphere andwere named R-Lesion, R-PeriInfarct and
R-Healthy. This was done by transforming the left hemi-
sphere masks into Montreal Neurological Institute (MNI)
standard space (see below), then flipping about the left/right
plane, and finally transforming it back into individual subject
space. R-Lesion, R-PeriInfarct and R-Healthy contained unaf-
fected tissue. Full left and right hemisphere masks compris-
ing all voxels (including those in the lesion and peri-infarct
regions) in the hemisphere were also defined and called L-
Hemi and R-Hemi, respectively. These were the only masks
used for theHV group.
The high-resolution structural images were registered to
the MNI space using FMRIB’s (http://www.fmrib.ox.ac.
uk/fsl/) Linear Image Registration Tool (FLIRT) with 12
degrees of freedom and cost-function masking to avoid
the known problem of stretching normal tissue to fill the
infarct during standard registration [Brett et al., 2001]. The
final transformation matrix was used to transform each
mask to standard space as stated above.
Breath-Hold Response Comparisons
Breath-hold responses for each of the three analyses
were averaged over each mask for comparison. However,
to remove voxels in which no breath-hold response was
observed (e.g., a white matter voxel in which blood vol-
ume is low), each mask was thresholded on the basis of
both the individual participant and the analysis method. A
liberal threshold of R25 0.03 (P5 0.05, for the number of
time points with no correction for multiple comparisons)
was used. If the GLM did not explain this amount of var-
iance in a voxel’s data, the voxel was removed from the
mask. This ensured that averages across the masks were
not skewed by voxels in areas of post-stroke atrophy that
may show no response. In each mask, both the percentage
of voxels surviving this threshold and their average var-
iance were calculated for all participants. Comparisons
between analysis methods and across masks were made
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using paired and unpaired t-tests. Specifically, differences in
the values in each mask across the analysis methods were
tested using paired t-tests. Similarly, differences within anal-
ysis method but across the masks were tested using paired
t-tests. Unpaired t-tests were used to test differences
between the HV and PT groups in the L-Hemi masks. These
results are presented in Figure 2 and discussed below.
The average voxel-wise delays across the masks, calcu-
lated using the VoxOpt analyses, were also compared for
both the SPPS and CPPS time points. The average delay
difference was calculated in the HV L-Hemi, PT
L-Healthy, PT L-PeriInfarct and PT L-Lesion masks with the
corresponding delay in the homologous mask as the base-
line. In this way, no difference in delay between the right
and left hemisphere yields a value of 0. T-tests against 0
determined whether the delays were significantly different
between the hemispheres. The results are shown in Figure
3 and discussed below.
CVR and %BOLD change responses were compared
across left and right masks and SPPS and CPPS time
points for both the VoxOpt and RHsig analyses, respec-
tively. Paired t-tests were used to determine significant
differences between masks within analysis methods and
between time points. Unpaired t-tests were used to com-
pare the PT and HV groups. The results are shown in Fig-
ure 4 and discussed below.
Finally, to determine whether the breath-hold responses
in the PT group change over time from SPPS to CPPS, the
Sess1 and Sess2 results from the 20 patients that provided
data for both phases were compared. Paired t-tests were
used to compare CVR results in each of the masks across
the time points. These results are shown in Figure 5 and
are discussed below.
RESULTS
Lesion Distributions
Stroke patients with recent left lateralized infarcts were
chosen to take part in the study. Figure 1a shows the dis-
tribution of the lesions across the participants at each of
the two phases, SPPS and CPPS. For the 24 patients
Figure 2.
The three analyses methods (GlobOpt, VoxOpt and RHsig) were
compared across different masks for Sess1 (similar results were
found for Sess2): the L-Hemi mask for both the HV and PT
groups and the L-Healthy (LH), L-PeriInfarct (LP) and L-Lesion (LL)
masks for the PT group. Grey bars depict the HV results and
white bars the PT results (bars show means, error bars show
standard deviations). The top panel shows the percentage of
voxels in each mask that passed the liberal fitting threshold
(R25 0.0288, P = 0.05, no correction for multiple comparisons)
averaged across subjects in each group. The bottom panel shows
the across voxel average variance explained in each thresholded
mask, averaged across the subjects in each group.
Figure 3.
Using the VoxOpt analysis, the delay between each individual
voxel time series and the end-tidal CO2 time series can be cal-
culated. With the assumption that the right hemisphere masks
are largely unaffected by the stroke, the delay in the left hemi-
sphere masks compared with their right homologous regions
are shown for both the SPPS and CPPS time points (bars show
means, error bars show standard deviations).
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scanned at SPPS, the mean percentage of left hemisphere
voxels deemed to be in L-Lesion was 1.6%, maximum 9%.
L-PeriInfarct comprised a mean of 7% of left hemisphere
voxels, maximum 22%. In the 42 patients scanned at
CPPS, L-Lesion comprised a mean of 3.2% of left hemi-
sphere voxels, maximum 21.2% and L-PeriInfarct 10.8%,
maximum 28.8%. In the 20 patients scanned at both SPPS
and CPPS, the mean lesion size reduced from 1.78% to
1.28% of left hemisphere voxels, a small but significant dif-
ference (t5 3.2, P = 5 3 1023).
Motion Related to the Breath-Hold Task
The average scan motion was calculated as the mean
frame-wise displacement (FWD) using the method
described by Power et al. [2012]. Across both sessions, the
mean FWD was 0.216 0.13 in the PT group and
0.176 0.08 in the HV group. An insignificant trend
(P5 0.06) towards greater motion in the PT group versus
the HV group was observed.
End-Tidal CO2 and the Global BOLD Signal
For the GlobOpt analysis, the delay at which the CO2
trace explained the most variance (as measure by R2) in
the BOLD signal was chosen (see Fig. 1c top panel). The
average R2 did not differ in either the PT group or the HV
group between the first and second time points (PT
Sess15 0.386 0.28; PT Sess25 0.386 0.24; HV
Sess15 0.586 0.21; HV Sess25 0.476 0.22). However, more
global signal variance was explained by the CO2 trace in
Figure 4.
Breath-hold responses averaged across participants (bars show
means, error bars show standard deviations). The top panel dis-
plays results from the VoxOpt analysis and the bottom panel
shows results from the RHsig analysis. White bars show results
from masks in the right hemisphere and grey bars show results
from the left hemisphere masks. For the HV group, whole hemi-
sphere masks were used. For the PT group at the two time
points (Sess1-SPPS and Sess2-CPPS), results from three masks in
each hemisphere are shown: Healthy, PeriInfarct and Lesion.
Figure 5.
Breath-hold responses averaged across patients with a scans at
both SPPS and CPPS time points (n5 20; bars show means, error
bars show standard deviations). The top panel displays results
from the VoxOpt analysis and the bottom panel shows results
from the RHsig analysis. The grey bars show results from the
first SPPS session and the white bars from the second CPPS ses-
sion. In both analyses, there were no significant differences
between the SPPS and CPPS responses in each of the four masks;
R-Hemi, L-Healthy, L-PeriInfarct and L-Lesion.
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the HV group versus the PT group (t = 3.2, P = 2 3 1023,
combining the data across both sessions).
Analysis Methods Comparison
Three types of breath-hold analyses were compared:
GlobOpt, VoxOpt and RHsig. Figure 2 shows the relative
performance of each of the methods by plotting the per-
centage of voxels that passed threshold in each mask (top
panel), and the average variance explained in each mask
across the participants for Sess1 (similar results were
observed in Sess2). Results from the HV group are shown
with grey bars. The percentage of voxels that passed
threshold in left hemisphere masks, L-Hemi, in this group
was 53.16 8.9% for the GlobOpt method, increasing to
68.66 7.4% for the VoxOpt analysis and 64.16 5.7% for the
RHsig method. Both the VoxOpt and RHsig values were
significantly greater than the GlobOpt values (P < 1027
and P = 9 3 1025, respectively). In the HV group, the var-
iance explained in L-Hemi voxels was 13.76 3.7, 14.36 3.6
and 17.96 3.4% for the GlobOpt, VoxOpt and RHsig analy-
sis methods, respectively. Again, both the VoxOpt and
RHsig values were significantly greater than the GlobOpt
values (P < 1027 and P = 9 3 1026, respectively) with the
RHsig analysis also explaining significantly more variance
than the VoxOpt method (P = 6 3 1025).
Similar trends were observed in left hemisphere mask, L-
Hemi, of the PT group, with significantly less voxels passing
threshold and significantly less variance explained with the
GlobOpt analysis than both the VoxOpt and the RHsig analy-
ses methods (% voxels: P < 1027 and P = 2.8 3 1025,
respectively; variance explained: P = 1.4 3 1023 and P = 1.2
3 1025, respectively). However, in all three analyses meth-
ods, the results were lower in L-Hemi in the PT group com-
pared the HV group. Less voxels passed threshold in L-
Hemi of the PT group compared with the HV group (Glo-
bOpt, P = 2 3 1023; VoxOpt, P = 4 3 1024; and RHSig, P =
9 3 1023). A trend was observed for more variance
explained in the HV compared with the PT group for the
GlobOpt analysis (P = 0.014), with significantly more var-
iance explained in both the VoxOpt and RHsig analyses (P
= 8.6 3 1023 and P = 7.2 3 1023, respectively). A similar
comparison between PT and HV in the R-Hemi mask, in
which areas should be unaffected, also shows decreases.
Significantly less voxels pass threshold in the PT group for
GlobOpt and VoxOpt analyses (P = 9.4 3 1023 and P = 2.0
3 1023). A trend for a reduction in the amount of variance
explained in the PT is observed in the R-Hemi masks for all
analyses methods, with VoxOpt reaching significance (P =
3.5 3 1022). This suggests that voxel time series are noisier
in the PT group than the HV group.
In the PT group, L-Hemi included not only tissue not
directly affected by ischemic damage but also the lesion
and the peri-infarct masks. Since this may have caused the
lower values in the PT group compared with the HV
group, L-Healthy, L-PeriInfarct and L-Lesion were also com-
pared in Figure 2. For all three analyses, the number of
voxels that passed the threshold in each mask, and the
variance explained, reduced from L-Healthy to L-PeriInfarct
and then to L-Lesion. Only in the GlobOpt analysis was the
reduction in the number of voxels significant (L-Healthy vs.
L-PeriInfarct, P = 4.7 3 1024; L-Healthy vs. L-Lesion, P = 1.7
3 1024). For the measure of explained variance, all analy-
ses showed significant reduction from L-Healthy to the
other two masks. For example, in the VoxOpt analysis, the
variance explained in L-Healthy was 11.36 4.1%, which
reduced significantly to 9.56 4.1% in L-PeriInfarct (P = 1.7
3 1023) and to 8.66 6.1% in L-Lesion (P = 3.3 3 1023).
Delays in Breath-Hold Responses Relative to the
Contralesional Hemisphere
The VoxOpt analysis allowed for a variable delay
between the CO2 trace and each voxel’s time series, inde-
pendent of other voxels. Figure 3 shows delays in the left
hemisphere masks compared with their homologous mask
in the right hemisphere. No difference in delays is defined
as 0 on this graph. In the HV group, who were also
scanned at two time points, the relative delay in L-Hemi
was 20.036 0.67 and 20.156 0.71 s for the Sess1 and Sess2,
respectively. Neither was significantly different from zero.
Similarly, the response in L-Healthy in the PT group was
not significantly delayed relative to the homologous right
hemisphere region, with mean delays of 0.036 0.89 and
20.026 0.87 s for the Sess1-SPPS and Sess2-CPPS data,
respectively. The responses in L-PeriInfarct and L-Lesion
showed a significant delay compared with their homolo-
gous right hemisphere regions at Sess1-SPPS, with delays of
1.146 2.4 s (P = 0.03) and 1.946 4.34 s (P = 0.04), respec-
tively. Likewise at Sess2-CPPS, the responses in L-PeriInfarct
and L-Lesion were also significantly delayed compared with
their right homologues with delays of 1.246 2.14 s (P = 5 3
1024) and 1.836 3.27 s (P = 7 3 1024), respectively. This
finding demonstrates the need to account for regional vari-
ability in delays to the CO2 trace in stroke-affected areas
during breath-hold analyses. These delays do not appear to
recover over the time periods tested in this study.
Breath-Hold Responses Across all Participants
The average breath-hold responses across all partici-
pants are displayed in Figure 4 for the VoxOpt (top panel)
and RHsig (bottom panel) analyses. For the HV group, val-
ues are shown in L-Hemi and R-Hemi for both Sess1 and
Sess2. For the PT group, both Sess1-SPPS and Sess2-CPPS,
the results of the ipsilesional mask are displayed in grey
bars (L-Healthy, L-PeriInfarct and L-Lesion) and results from
the right hemisphere are depicted in white bars (R-Healthy,
R-PeriInfarct and R-Lesion).
In the HV group, similar breath-hold response levels
were observed in both hemispheres and across sessions.
For the VoxOpt analysis, Sess1 showed mean responses of
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0.326 0.09 and 0.316 0.09, and the corresponding values
for Sess2 were 0.306 0.07 and 0.296 0.06, for R-Hemi and
L-Hemi, respectively (units: %BOLD per mmHg change in
end-tidal CO2). For the RHsig analysis, the average
responses were 1476 11 and 1416 12 for Sess1 and
1496 12 and 1426 15 for Sess2 (units: %BOLD). Although
the differences were small between hemispheres, they were
significant for the RHsig analysis in both Sess1 (P = 2.1 3
1024) and Sess2 (P = 9.6 3 1023). This might be expected,
because the regressor for the RHsig analysis was drawn
from R-Hemi, and therefore, was a slightly better fit to the
voxels in that hemisphere. However, a similar significant
difference was also observed for the VoxOpt analysis in
both Sess1 (P = 5.9 3 1023) and Sess2 (P = 0.023).
In the PT group, similar levels of response compared with
the HV group were observed in the healthy tissue masks.
For the VoxOpt analysis, the response in L-Healthy was
0.296 0.12 and 0.306 0.10 for Sess1 and Sess2, respectively
(%BOLD per mmHg). The corresponding results for the
RHsig analysis were 1436 30 and 1436 17 (%BOLD). For the
two methods, there was a drop in response when going
from Healthy to PeriInfarct to Lesion in both the stroke-
affected left hemisphere masks as well as the contralesional
right hemisphere masks. For example, at SPPS with the Vox-
Opt method, the response dropped from 0.296 0.12 to
0.216 0.09 (P5 4 3 1025) and to 0.196 0.17 (although not
significantly, P5 0.1) in L-Healthy, L-PeriInfarct and L-Lesion.
Similar declines from 0.306 0.12 to 0.236 0.10 (P5 5.3 3
1024) and then to 0.196 0.11 (P5 2 3 1023) were also
observed in the right hemisphere. This demonstrated that
the definition of the masks changed the response levels on
the supposedly unaffected right hemisphere side.
In the comparison between left and right hemisphere
masks, the RHsig method appears to have distinguished
the affected ipsilesional from the unaffected contralesional
masks better, because the observed decline in response
was greater on the left side (assuming that we would
expect a decline in CVR on the lesioned side). For exam-
ple, at CPPS the response difference was 1566 16 in R-
Healthy compared with 1136 61 in R-Lesion, but on the
affected side the difference was much greater, 1426 17
compared with 756 56. Although, the left/right differen-
ces in the VoxOpt analysis appear small, paired t-tests
showed differences in Healthy (Sess1, P = 1.1 3 1023; Sess2,
P = 8.3 3 1024) and PeriInfarct (Sess1, P = 7.8 3 1024;
Sess2: P = 9.5 3 1024) but not Lesion in both sessions. The
same comparisons in the three masks for the RHsig analy-
sis showed more significant differences: P = 6.4 3 1024, P
= 4 3 1024 and P = 0.015 for Sess1-SPPS; P < 1027, P <
1027 and P < 3.6 3 1023 for Sess2-CPPS, respectively.
Longitudinal Changes in Breath-Hold Responses
in 20 Patients with Two Scans
To determine whether reduced CVR recovers over time,
Sess1-SPPS and Sess2-CPPS were compared in the 20
patients who were scanned twice (Fig. 5). For the VoxOpt
analysis method (top panel) at the SPPS time point (grey
bars), there was no significant difference between the
mean responses in the R-Hemi and L-Healthy masks
(0.296 0.13 and 0.286 0.13, respectively). The breath-hold
responses were significantly reduced to 0.206 0.10 in the
L-PeriInfarct mask (P = 6.7 3 1024). Although the L-PeriIn-
farct had a similar response to the L-Lesion mask
(0.196 0.18), due to a large standard deviation of the L-
Lesion responses, the difference between the L-Lesion and
L-Healthy was not significant (P = 0.093). Almost identical
values were observed for all four masks at CPPS (white
bars). Importantly there was no significant difference
between SPPS and CPPS in all the masks (P > 0.5).
Using the RHsig analysis (bottom panel of Fig. 5) at the
SPPS time point (grey bars), the breath-hold response in
the L-Healthy mask was significantly less than that in R-
Hemi mask (1346 29 and 1536 23, respectively: P = 2.8 3
1023). Again, since the RHsig draws its regressor from the
right hemisphere, this may not be surprising. There was a
significant reduction from the L-Healthy response to 96656
in the L-PeriInfarct mask (P = 8.1 3 1024) and to 756 99 in
the L-Lesion mask (P = 6.5 3 1023). As with the VoxOpt
analysis, no differences existed between responses in the
SPPS and CPPS time points (P > 0.2), demonstrating that
reductions in the breath-hold response in the Lesion and
PeriInfarct masks did not recover over the time course of
this study.
Results Summary
The VoxOpt and RHsig analyses fit the breath-hold data
better than the GlobOpt analysis (Fig. 2). Delays in the
breath-hold response in the L-PeriInfarct and L-Lesion
masks are observed in the PT group at both the SPPS and
CPPS time points (Fig. 3). At both time points, the CVR
measures decrease from the Healthy to the PeriInfarct to the
Lesion regions (Fig. 4). The decreased CVR in the L-PeriIn-
farct and L-Lesion masks does not recover over time
(Fig. 5).
DISCUSSION
Erroneous interpretation of BOLD fMRI group results
can be caused by stroke-induced changes in CVR. Bright
and Murphy [2013] have previously established that CVR
can be reliably quantified with breath-hold tasks, even
when poorly performed, demonstrating that this approach
is useful in patients who may not comply fully with the
task. Since stroke has a vascular etiology, changes to CVR,
especially within the infarct and the peri-infarct tissue,
might be expected, making this a pathology for which this
simple measure of CVR may be well used.
In this study, patients with left hemisphere infarcts were
examined. In the sub-group of patients that were scanned
twice, SPPS and CPPS time points were approximately 4
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months apart. A steady state of recovery is assumed at the
CPPS time point since it has been shown that clinically,
maximum recovery has been reached after 3 months,
beyond which the rate of recovery plateaus and very little
further recovery occurs [Laska et al., 2001; Pedersen et al.,
1995; Ward et al., 2003].
In all patients, masks of four separate regions were
defined: the lesion itself (L-Lesion); the peri-infarct tissue
(L-PeriInfarct); the regions in the left hemisphere unaf-
fected by stroke (L-Healthy) and the unaffected contrale-
sional right hemisphere (R-Hemi). The peri-infarct tissue
was arbitrarily defined as a 10-mm wide region around
the lesion. This mask was included in the analysis as some
studies have attributed activity or lack of activity, in the
peri-infarct tissue to stroke recovery [Heiss et al., 1999,
2006; Rosen et al., 2000; Saur, 2006; Ward et al., 2003].
Although this mask was arbitrarily defined and may not
fully overlap with affected areas, it was included as an
example of a region that might have reduced CVR. In a
BOLD study investigating recovery after stroke, any other
region could be analysed in a similar way to determine if
CVR changes are likely to cause interpretability problems
for that region.
One aspect of the lesion and peri-infarct BOLD data that
might change compared with healthy tissue is the
response delay to the breath-hold. Previously, studies have
used the end-tidal CO2 trace as a regressor in a GLM
[Bright and Murphy, 2013; Murphy et al., 2011] to produce
a CVR measure that is comparable across subjects. If a
region has a delayed response that is unaccounted for, the
CVR measure might be artificially reduced. For this rea-
son, we performed two methods of analysis with the CO2
trace: GlobOpt and VoxOpt. The GlobOpt method represents
the standard analysis for breath-hold data in which the
same regressor is used for all voxels. The VoxOpt analysis
allows for a voxel-wise delay. Figure 3 demonstrates that
the delay between the responses within the peri-infarct
and lesion tissue response compared with the responses in
their homologous regions on the contralateral side can be
appreciable [1.246 2.14 s (P = 5 3 1024) and 1.836 3.27s
(P = 7 3 1024), respectively]. This can explain why less
voxels passed threshold in GlobOpt analysis versus the
VoxOpt analysis (Fig. 2). For this reason, the VoxOpt analy-
sis was considered superior to the GlobOpt analysis, which
was dropped from further study.
The VoxOpt analysis requires an end-tidal CO2 trace,
which may not be available in all situations. In addition,
patients may have difficulties using the nasal cannula,
especially if they prefer to breathe through the mouth, or
the equipment may not be available in all settings. The
finding that more global signal variance is explained by
the end-tidal CO2 trace in the HV group versus the PT
group suggests that the end-tidal CO2 recordings in the
patient group may be less reliable. For this reason, the
RHsig analysis, in which the model of breath-hold signal
change is derived from the contralesional hemisphere,
was also compared. A similar number of voxels passed
threshold with this method compared with the VoxOpt
method. However, the RHsig method also explained sig-
nificantly more variance in those voxels that passed
threshold (Fig. 2). Perhaps this is not so surprising since
the regressor derived from the RHsig is more likely to
resemble a BOLD response than an end-tidal CO2 trace
convolved with a standard HRF. The advantages of the
RHsig method are that it is a better fit to the individual
voxel BOLD responses, and it does not need end-tidal
CO2 traces that require equipment and setup time that
may not result in accurate recordings. Conversely, there
are a number of disadvantages to the RHsig compared
with the VoxOpt technique: it may not be truly compara-
ble across subjects, since it is not a quantitative measure
and, therefore, not suitable for correcting task-related
BOLD responses; it requires an assumption of where
unaffected regions lie (indeed, in this study, seven of the
R-Hemi masks were slightly contaminated by small
lesions in the right hemisphere); it does not account for
delays between the model and a voxel’s BOLD response;
the model is an average over voxels that may have differ-
ing delays, and will, therefore, represent a more dis-
persed HRF; and finally, the CVR measures are biased
towards the mask from which the regressor is derived, in
this case R-Hemi, and so may not be reliable across the
entire brain.
Since it was difficult to determine which analysis
approach was superior, results from both VoxOpt and
RHsig analyses were investigated further. Comparisons of
the responses in healthy unaffected tissue in the PT group
with responses in the HV group showed no differences
(Fig. 4). Although the number of voxels passing threshold
is less, this suggests the CVR measures are as reliable in
the patient group as the healthy controls. In both analyses,
the CVR measure reduces as the mask size decreases
(from Healthy to PeriInfarct and then Lesion) on both the
stroke-affected left hemisphere and the contralesional right
hemisphere. It is possible that this represents a reduction
in CVR due to the anatomical location of the masks. How-
ever, since the lesions are in largely heterogeneous loca-
tions (Fig. 1), it is more likely that this reduction is simply
a function of mask size.
The interesting question is how the masks on the left
side compare with their homologous masks on the right.
A small but significant difference in CVR between the
healthy tissue masks of the right and left hemisphere for
the PT group might be indicative of increased cerebrovas-
cular disease on the stroke-affected left side of the brain.
However, since a similar small significant difference is
observed between the L-Hemi and R-Hemi mask in the
HV group, it is difficult to determine whether this is the
case. For the peri-infarct mask compared with its homo-
logue, small but significant differences were observed
with the VoxOpt analysis, and much larger and significant
differences observed with the RHsig analysis. Only the
RHsig analysis showed differences in CVR between the
lesion and its homologue (Fig. 4). If we expect that CVR
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is reduced in the lesion, this might suggest that the RHsig
is better at distinguishing CVR changes in that area.
However, from Figure 3, we know that there was a delay
in the BOLD response in the lesion that was not
accounted for by the RHsig analysis, which might have
lead to the reduced CVR measures in the lesion com-
pared with its homologue. From Figure 2, we can observe
that the number of voxels that passed threshold was
reduced in the lesion but it is possible that these voxels
had intact CVR, albeit delayed, which the VoxOpt analy-
sis captured but the RHsig method could not. Although
differences exist, both methods provide similar interpreta-
tions of the data.
It is important to note that a breath-hold challenge results
in mild hypoxia alongside the intended hypercapnia. Since
oxygen is vasoactive, this might directly influence the BOLD
contrast [Bulte et al., 2012]. A previous study has shown that
breath-hold induced changes in end-tidal O2 and CO2 traces
are significantly negatively correlated [Bright and Murphy,
2013], thus their respective effects on BOLD signal changes
are difficult to disentangle. However, it has been shown that
there is minimal impact on CBF when end-tidal O2 ranges
from 60 to 150 mmHg [Brugniaux et al., 2007]; all changes to
the breath-hold task fall well within this range. A recent
study comparing CVR measures derived from breath-hold
paradigms and gas challenges demonstrated that mild
hypoxia caused by breath-holds did not significantly alter
CVR results compared with an iso-oxic CO2 challenge [Tan-
credi and Hoge, 2013]. These studies indicate that the mild
hypoxia caused by the breath-hold challenge should not
influence the CVR values in this study.
The peri-infarct region is important when studying
stroke recovery. Many longitudinal BOLD fMRI studies
focus on activity in the peri-infact tissue, to determine if
neural activity has returned to what would be expected in
healthy brains [Saur, 2006; Ward et al., 2003]. Others have
attributed activity in the peri-infarct region, or lack of it, to
stroke recovery [Heiss et al., 1999, 2006; Rosen et al., 2000].
Alterations in the peri-infarct CVR over time, may
adversely affect the interpretation of task-related BOLD
signal change in fMRI studies of patients in the acute
stages of stroke or in longitudinal studies. In this study,
for both the VoxOpt and RHsig analysis methods, the CVR
in the peri-infarct tissue was shown to be reduced com-
pared with the healthy tissue in the stroke-affected hemi-
sphere, but did not change between the sub-acute and
chronic phases after the ictus (Fig. 5). These findings sug-
gests that in the cohort of patients studied, a relative lack
of group-level task-related BOLD signal in the peri-infarct
tissue compared with the healthy controls, may not accu-
rately reflect neural deficits. However, since CVR in the
peri-infarct tissue remains unchanged over time, a finding
of increased group-level peri-infarct activity in the chronic
phase in such a longitudinal study is less likely to be due
to changes in vascular reactivity, and may be more reliably
interpreted as a change in neural activity in the peri-
infarct tissue after stroke.
CONCLUSIONS
This study demonstrates that CVR can be measured suc-
cessfully in a stroke patient population using a breath-
hold task. The resulting CVR measures can be used to dis-
entangle vascular and neural changes caused by stroke,
increasing confidence when interpreting group-level BOLD
signal results in terms of neural activity (oxygen consump-
tion). A lack of CVR differences in healthy tissue between
patients and controls in this cohort suggests that task-
related BOLD signal changes in these regions should be
unaffected by the stroke and be more representative of
task-related oxygen metabolism. In contrast, since CVR is
reduced in the stroke peri-infarct tissue, a lack of BOLD
signal in that area compared with controls may not accu-
rately reflect neural deficits. However, the CVR in the
peri-infarct tissue remains unchanged over time, suggest-
ing that any group-level BOLD increases in this region
over time in a longitudinal fMRI study are less likely to be
due to an improvement in vascular reactivity, and may be
more confidently attributed to changes oxygen metabolism
caused by altered neural function. This study provides a
framework for stroke researchers to account for CVR-
related confounds in BOLD fMRI stroke studies. By
including a similar breath-hold protocol in longitudinal
studies of stroke recovery and performing similar analy-
ses, researchers can more confidently interpret BOLD sig-
nal changes by disentangling vascular and neural
influences using this method.
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